{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T21:13:38Z","timestamp":1777929218065,"version":"3.51.4"},"reference-count":33,"publisher":"SAGE Publications","issue":"9","license":[{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Lupus"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>This study aims to investigate the protective effect of esculentoside A (EsA) on lupus nephritis (LN) by modulating the mucosal-associated invariant T (MAIT) cells and associated cytokines in the renal tissue of MRL\/lpr mice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Eighteen 16-week-old female MRL\/lpr mice were randomly assigned into the model and EsA groups (9 mice each), and 9 age-matched female Balb\/c mice were included as a normal group. Mice were administered 0.2\u00a0mL of EsA solution (2.5\u00a0mg\/mL) or RPMI 1640 medium (for control groups) via intraperitoneal injection once daily for 4\u00a0weeks. Urine protein\/creatinine ratio (URCR) and blood creatinine (Cr) concentration were measured, Hematoxylin-eosin and Masson staining of renal tissues were performed, and the \u201cAustin\u201d acute index (AI) system for LN was determined and the protein expression of TNF-\u03b1, IFN-\u03b3, IL-2, and IL-17 were assessed by Western blot. The proportion of MAIT cells in kidney tissues was analyzed using flow cytometry. Pearson correlation analysis was performed between renal MAIT cells and the expression of TNF-\u03b1, IFN-\u03b3, IL-2, and IL-17 proteins in kidney tissues. Data were analyzed with SPSS 26.0 software.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared with the normal group, the model group exhibited significantly elevated levels of Cr, UCPR, renal expression of TNF-\u03b1, IFN-\u03b3, and IL-17, as well as an increased proportion of MAIT cells, along with the most severe renal histopathological damage and the highest AI score. In contrast, the EsA group showed a notable reduction in these parameters, although they remained elevated compared to the normal group. Kidney IL-2 expression was significantly lower in the model group than in the normal group, while EsA treatment resulted in an increase in IL-2 levels. Renal MAIT cells were positively correlated with TNF-\u03b1, IFN-\u03b3, and IL-17 expression but negatively correlated with IL-2.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>EsA confers protection against LN in MRL\/lpr mice by downregulating the proportion of MAIT cells in kidney tissue, reducing the expression of pro-inflammatory cytokines (TNF-\u03b1, IFN-\u03b3, IL-17), and increasing IL-2 expression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/09612033251348151","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T04:03:32Z","timestamp":1749096212000},"page":"912-921","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Esculentoside A alleviates lupus nephritis by modulating MAIT cells in MRL\/lpr mice"],"prefix":"10.1177","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-2698-6739","authenticated-orcid":false,"given":"Xing","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Nephrology and Rheumatology, The Fifth Affiliated Hospital of Zunyi Medical University, Zhuhai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxue","family":"Weng","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Sanshui District People\u2019s Hospital, Foshan City, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianghui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Rheumatology, The Fifth Affiliated Hospital of Zunyi Medical University, Zhuhai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Rheumatology, The Fifth Affiliated Hospital of Zunyi Medical University, Zhuhai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianggui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Rheumatology, The Fifth Affiliated Hospital of Zunyi Medical University, Zhuhai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jieyin","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Rheumatology, The Fifth Affiliated Hospital of Zunyi Medical University, Zhuhai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,6,5]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2018.05.041"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203318789788"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203317751852"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01014"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-020-0332-4"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0444-8"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.4c12997"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/imcb.12008"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2019.08.054"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.819992"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0191-y"},{"key":"e_1_3_4_13_2","unstructured":"Sun WX Sheng YH Huang J et al. Study on the pharmacodynamics and pharmacokinetics of Phytolacca acinosa and its efficacy mechanism. Chin Pharmacol Bull 2022; 38(9): 1429\u20131434."},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2021.06.017"},{"key":"e_1_3_4_15_2","unstructured":"Tan ZF Li JQ Yu Y et al. Esculentoside A inhibits the TLR4\/NF-\u03baB signaling pathway to improve atherosclerosis in rats. Drug Evaluation Research 2022; 45(12): 2509\u20132514."},{"issue":"16","key":"e_1_3_4_16_2","first-page":"2183","article-title":"The effect of Esculentoside A on the activation of ERK1\/2-AP-1 pathway in IL-1\u03b2-induced glomerular mesangial cells","volume":"46","author":"Tang JY","year":"2017","unstructured":"Tang JY, Dong Y, Zhang XG, et al. The effect of Esculentoside A on the activation of ERK1\/2-AP-1 pathway in IL-1\u03b2-induced glomerular mesangial cells. Chongqing Medical Journal 2017; 46(16): 2183\u20132186.","journal-title":"Chongqing Medical Journal"},{"issue":"05","key":"e_1_3_4_17_2","first-page":"483","article-title":"Effects of Esculentoside A on iTr35 cells and related cytokines expression in MRL\/lpr mice","volume":"47","author":"Wang X","year":"2019","unstructured":"Wang X, Zeng HL, Zhang XG, et al. Effects of Esculentoside A on iTr35 cells and related cytokines expression in MRL\/lpr mice. Tianjin Medicine 2019; 47(05): 483\u2013487.","journal-title":"Tianjin Medicine"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","unstructured":"Jones-Bolin S. Guidelines for the care and use of laboratory animals in biomedical research. Curr Protoc PharmacolAppendix. 2012 Dec; 4:Appendix 4B. DOI: 10.1002\/0471141755.","DOI":"10.1002\/0471141755"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1080\/08830185.2020.1742712"},{"issue":"12","key":"e_1_3_4_20_2","first-page":"1540","article-title":"The therapeutic effect of Esculentoside A on BXSB lupus nephritis mice","volume":"32","author":"Ma HL","year":"2011","unstructured":"Ma HL, Zhang XZ, Zhang XG. The therapeutic effect of Esculentoside A on BXSB lupus nephritis mice. Guangdong Medical Journal 2011; 32(12): 1540\u20131542.","journal-title":"Guangdong Medical Journal"},{"issue":"09","key":"e_1_3_4_21_2","first-page":"927","article-title":"The effect of Esculentoside A on apoptosis in BXSB mice with lupus nephritis","volume":"24","author":"Ma HL","year":"2015","unstructured":"Ma HL, Zhang XG, Yang D, et al. The effect of Esculentoside A on apoptosis in BXSB mice with lupus nephritis. Modern Journal of Integrated Traditional Chinese and Western Medicine 2015; 24(09): 927\u2013929.","journal-title":"Modern Journal of Integrated Traditional Chinese and Western Medicine"},{"key":"e_1_3_4_22_2","volume-title":"The effect of Esculentoside A on renal inflammation and CD19+IL-35+Breg cells, IL-35 expression in MRL\/lpr mice","author":"Zeng HL","year":"2020","unstructured":"Zeng HL. The effect of Esculentoside A on renal inflammation and CD19+IL-35+Breg cells, IL-35 expression in MRL\/lpr mice. Zunyi, China: Zunyi Medical University, 2020."},{"issue":"12","key":"e_1_3_4_23_2","first-page":"3","article-title":"Effect of Esculentoside A on the differentiation of CD4+ T cells to Th17","volume":"39","author":"Tang JY","year":"2019","unstructured":"Tang JY, Zhang W, Zhang XG. Effect of Esculentoside A on the differentiation of CD4+ T cells to Th17. Basic & Clin Med 2019; 39(12): 3.","journal-title":"Basic & Clin Med"},{"key":"e_1_3_4_24_2","first-page":"42","article-title":"Research progress on the traditional Chinese medicine Phytolacca acinosa","volume":"4","author":"Yuan ST","year":"1991","unstructured":"Yuan ST, Wang ZJ, Cheng M. Research progress on the traditional Chinese medicine Phytolacca acinosa. Chinese Medicinal Materials 1991; 4: 42\u201344.","journal-title":"Chinese Medicinal Materials"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02681"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/cei\/uxad058"},{"key":"e_1_3_4_27_2","volume-title":"The correlation between Th17 and IL-17 with chronic kidney disease and micro-inflammatory states","author":"Xiong LL","year":"2022","unstructured":"Xiong LL. The correlation between Th17 and IL-17 with chronic kidney disease and micro-inflammatory states. Kunming: Kunming University of Science and Technology, 2022."},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-0207-2_1"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-021-05527-y"},{"issue":"8","key":"e_1_3_4_30_2","first-page":"5","article-title":"Research progress on the role of IL-2 in systemic lupus erythematosus","volume":"38","author":"Zeng J","year":"2022","unstructured":"Zeng J, Zhai ZF. Research progress on the role of IL-2 in systemic lupus erythematosus. Chinese Journal of Immunology 2022; 38(8): 5.","journal-title":"Chinese Journal of Immunology"},{"issue":"15","key":"e_1_3_4_31_2","first-page":"249","article-title":"Pharmacological and clinical research on the traditional Chinese medicine Phytolacca acinosa","volume":"8","author":"Huang GY","year":"2013","unstructured":"Huang GY, Liu XX. Pharmacological and clinical research on the traditional Chinese medicine Phytolacca acinosa. China Practical Medicine 2013; 8(15): 249\u2013250.","journal-title":"China Practical Medicine"},{"issue":"20","key":"e_1_3_4_32_2","first-page":"224","article-title":"Anti-inflammatory components of Chinese herbal medicines and their mechanisms","volume":"8","author":"Zhan N","year":"2010","unstructured":"Zhan N, Lu D, Li PY. Anti-inflammatory components of Chinese herbal medicines and their mechanisms. Zhongguo Yiyao Zhinan (China Medical Guide) 2010; 8(20): 224\u2013226.","journal-title":"Zhongguo Yiyao Zhinan (China Medical Guide)"},{"issue":"18","key":"e_1_3_4_33_2","first-page":"2722","article-title":"Research progress on chemical constituents, pharmacological effects and clinical applications of Phytolacca acinosa","volume":"45","author":"Wang PC","year":"2014","unstructured":"Wang PC, Wang QH, Zhao S, et al. Research progress on chemical constituents, pharmacological effects and clinical applications of Phytolacca acinosa. Zhongcaoyao 2014; 45(18): 2722\u20132731.","journal-title":"Zhongcaoyao"},{"issue":"01","key":"e_1_3_4_34_2","first-page":"105","article-title":"Research progress of MAIT cells in autoimmune diseases","volume":"35","author":"Huang Q","year":"2019","unstructured":"Huang Q, Wang YZ, Li LX, et al. Research progress of MAIT cells in autoimmune diseases. Chinese Journal of Immunology 2019; 35(01): 105\u2013109.","journal-title":"Chinese Journal of Immunology"}],"container-title":["Lupus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09612033251348151","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/09612033251348151","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09612033251348151","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T23:29:03Z","timestamp":1777678143000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/09612033251348151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,5]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10.1177\/09612033251348151"],"URL":"https:\/\/doi.org\/10.1177\/09612033251348151","relation":{},"ISSN":["0961-2033","1477-0962"],"issn-type":[{"value":"0961-2033","type":"print"},{"value":"1477-0962","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,5]]}}}